OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$20.16
-0.16 (-0.79 %)
(As of 07/27/2021 03:59 PM ET)
Add
Compare
Today's Range
$20.04
$20.60
50-Day Range
$19.32
$22.14
52-Week Range
$17.83
$22.99
Volume29,848 shs
Average Volume38,913 shs
Market Capitalization$26.19 billion
P/E Ratio42.00
Dividend Yield0.79%
Beta0.67
30 days | 90 days | 365 days | Advanced Chart
Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.


Olympus logo

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Imaging Business segment provides digital cameras, IC and voice recorders, mirrorless interchangeable-lens cameras, and interchangeable lenses. The Others segment offers biomedical materials. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and GI- and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.35 out of 5 stars

Medical Sector

1015th out of 2,218 stocks

Structural Clay Products Industry

1st out of 3 stocks

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

Is Olympus a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus
or view top-rated stocks.

What stocks does MarketBeat like better than Olympus?

Wall Street analysts have given Olympus a "Strong Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Olympus wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Olympus?

Olympus saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 500 shares, a decrease of 96.9% from the June 30th total of 16,000 shares. Based on an average trading volume of 154,000 shares, the days-to-cover ratio is presently 0.0 days.
View Olympus' Short Interest
.

When is Olympus' next earnings date?

Olympus is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Olympus
.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) announced its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.29 billion.
View Olympus' earnings history
.

How has Olympus' stock price been impacted by COVID-19?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, OCPNY shares have increased by 14.1% and is now trading at $20.16.
View which stocks have been most impacted by COVID-19
.

Is Olympus a good dividend stock?

Olympus pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.79%. The dividend payout ratio of Olympus is 33.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 20.00% next year. This indicates that Olympus will be able to sustain or increase its dividend.
View Olympus' dividend history.

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Hiroyuki Tsuji, Director
  • Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 64)
  • Mr. Chikashi Takeda, Exec. Officer & CFO (Age 59)
  • Mr. Nacho Abia, COO & Exec. Officer (Age 53)
  • Mr. Akihiro Taguchi, CTO & Exec. Officer (Age 63)
  • Mr. Stefan Kaufmann, Chief Admin. Officer, Exec. Officer & Director (Age 53)
  • Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
  • Ms. Caroline H. West, Chief Compliance Officer (Age 63)
  • Mr. Mark Miller, Global Chief Communications Officer
  • Shigeto Ohtsuki, Corp. Officer & HR Head

Who are some of Olympus' key competitors?

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $20.16.

How much money does Olympus make?

Olympus has a market capitalization of $26.19 billion and generates $6.89 billion in revenue each year. The company earns $121.43 million in net income (profit) each year or $0.48 on an earnings per share basis.

How many employees does Olympus have?

Olympus employs 31,653 workers across the globe.

Does Olympus have any subsidiaries?

The following companies are subsidiares of Olympus: AVS Co Ltd, Aizu Olympus Co Ltd, Algram Group Ltd, Aomori Olympus Co Ltd, Arc Medical Design Limited, Image Stream Medical Inc, Nagano Olympus Co Ltd, Olympus (Beijing) Sales & Service Co Ltd, Olympus (China) Co Ltd, Olympus (GuangZhou) Industrial Co Ltd, Olympus (Malaysia) Sdn Bhd, Olympus (Thailand) Co Ltd, Olympus America Inc, Olympus America de Mexico SA de CV, Olympus Australia Pty Ltd, Olympus Austria Gesellschaft mbH, Olympus Belgium SA/NV, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group sro, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Digital System Design Corp, Olympus Estonia Oü, Olympus Europa SE & Co KG, Olympus Finland OY, Olympus France SAS, Olympus Hong Kong and China Limited, Olympus Iberia SAU, Olympus Ireland, Olympus Italia SRL, Olympus Korea Co Ltd, Olympus Latin America Inc, Olympus Logitex Co Ltd, Olympus MEA FZ-LLC, Olympus Medical Science Sales Corp, Olympus Medical Systems Corp, Olympus Medical Systems India Private Limited, Olympus Medical Systems Vietnam Co Ltd, Olympus Memory Works Corp, Olympus Moscow Limited Liability Company, Olympus NDT Canada Inc, Olympus Nederland BV, Olympus New Zealand Limited, Olympus Norge A/S, Olympus Optical do Brasil Ltda, Olympus Polska sp zoo, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc, Olympus Singapore Pte Ltd, Olympus Soft Imaging Solutions GmbH, Olympus Surgical Technologies America Inc, Olympus Surgical Technologies Europe (Olympus Winter & Ibe GmbH), Olympus Sverige AB, Olympus Systems Corporation, Olympus Taiwan Co Ltd, Olympus Terumo Biomaterials Corp, Olympus Trading (Shanghai) Limited, Olympus UK & Ireland, Olympus Vietnam Co Ltd, Olympus doo Beograd, Olympus-RMS Corp, Olympus-Supportmate Corp, Shirakawa Olympus Co Ltd, Sony Olympus Medical Solutions Inc, Tecnologias Opticas e Digitais Lda, and TmediX Corporation.

When was Olympus founded?

Olympus was founded in 1919.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

Where are Olympus' headquarters?

Olympus is headquartered at SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.